Tumor responsiveness to mevalonate pathway inhibitors require overexpression of the Arf6 pathway

Ari Hashimoto

2:45 PM - 3:45 PM

[1P-268] Tumor responsiveness to mevalonate pathway inhibitors require overexpression of the Arf6 pathway

^○Ari Hashimoto, Shigeru Hashimoto, Tsukasa Oikawa, Yutaro Otsuka, Haruka Handa, Yasuhito Onodera, Hisataka Sabe (Dept. of Mol. Biol., Hokkaido Univ. Grad. Sch. of Med.)

Arf6, 薬剤耐性, EMT, メバロン酸経路, p53

ahashimo@med.hokudai.ac.jp

Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.

You need the membership number and password to access the member page. Please contact the journal office for any inquiries.

Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934

The 89th Annual Meeting of JBS

[1P-268] Tumor responsiveness to mevalonate pathway inhibitors require overexpression of the Arf6 pathway

Password